Samir K. Gupta, MD

Professor of Medicine
Indiana University School of Medicine

Disclosure(s): Gilead Sciences: Advisor/Consultant; GSK/ViiV: Advisor/Consultant, Grant/Research Support

Poster(s):

• 1288 - US Healthcare Provider Perspectives on the initiation of cabotegravir and rilpivirine long-acting (CAB+RPV LA) in an observational real-world study (BEYOND)
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET